SCHEMBL2965102

SCHEMBL2965102

c1ccc2c(c1)nc(NCCCNCCCNc1nc3ccccc3c3[nH]c4ccccc4c13)c1c3ccccc3[nH]c21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO1 P15559 1/20 0.55
▸ GSK3A P49840 1/20 0.55
▸ GSK3B P49841 1/20 0.55
▸ PAX8 Q06710 1/20 0.54
▸ DYRK1A Q13627 1/20 0.49
▸ TERT O14746 8/20 0.48
▸ KDM4E B2RXH2 4/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ LMNA P02545 2/20 0.46
▸ POLB P06746 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ HPGD P15428 2/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ MAPK10 P53779 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ UTS2R Q9UKP6 4/20 0.44
▸ CYP3A4 P08684 3/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ KCNH2 Q12809 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3510900 0.99 PAX8 (0.56) NQO1GSK3AGSK3BPAX8DYRK1A
SCHEMBL2967645 0.86 NQO1 (0.63) NQO1GSK3AGSK3BPAX8DYRK1A
Hydrochloric Acid SCHEMBL3509482 0.85 TERT (0.52) NQO1GSK3AGSK3BPAX8DYRK1A
Hydrochloric Acid SCHEMBL3508543 0.85 PAX8 (0.64) NQO1GSK3AGSK3BPAX8DYRK1A
Hydrochloric Acid SCHEMBL3511768 0.84 TERT (0.60) NQO1GSK3AGSK3BPAX8DYRK1A
SCHEMBL13243586 0.84 UTS2R (0.60) NQO1GSK3AGSK3BPAX8DYRK1A
SCHEMBL29615014 0.82 TERT (0.63) NQO1GSK3AGSK3BPAX8DYRK1A
SCHEMBL3510262 0.82 TERT (0.63) NQO1GSK3AGSK3BPAX8DYRK1A
SCHEMBL13243587 0.80 NQO1 (0.47) NQO1GSK3AGSK3BPAX8TERT
SCHEMBL2969441 0.79 EGFR (0.52) NQO1GSK3AGSK3BPAX8DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763633-B2 Indolo[3,2-c]quinoline compounds KAOHSIUNG MEDICAL UNIVERSITY (TW) 2010-07-27 — — US disclosed
US-7763633-B2 Indolo[3,2-c]quinoline compounds KAOHSIUNG MEDICAL UNIVERSITY (TW) 2010-07-27 — — US disclosed
US-7763633-B2 Indolo[3,2-c]quinoline compounds KAOHSIUNG MEDICAL UNIVERSITY (TW) 2010-07-27 — — US disclosed
US-20090298846-A1 Indolo[3,2-c]quinoline Compounds KAOHSIUNG MEDICAL UNIVERSITY (TW) 2009-12-03 — — US disclosed
US-20090298846-A1 Indolo[3,2-c]quinoline Compounds KAOHSIUNG MEDICAL UNIVERSITY (TW) 2009-12-03 — — US disclosed
US-20090298846-A1 Indolo[3,2-c]quinoline Compounds KAOHSIUNG MEDICAL UNIVERSITY (TW) 2009-12-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298846-A1 Indolo[3,2-c]quinoline Compounds TERT, TERF2, CDKN1A NQO1 75/4885GSK3A 1875/4885GSK3B 1757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback